{"address1": "149 Fifth Avenue", "address2": "Suite 500", "city": "New York", "state": "NY", "zip": "10010", "country": "United States", "phone": "212 994 8200", "website": "https://www.protagenic.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.", "fullTimeEmployees": 1, "companyOfficers": [{"maxAge": 1, "name": "Dr. Garo H. Armen Ph.D.", "age": 71, "title": "Co-Founder & Executive Chairman of the Board", "yearBorn": 1953, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alexander Kenneth Arrow C.F.A., M.D.", "age": 53, "title": "CFO & Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 150000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew  Slee Ph.D.", "age": 74, "title": "Chief Operating Officer", "yearBorn": 1950, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert Benjamin Stein M.D., Ph.D.", "age": 73, "title": "Chief Medical Officer & Director", "yearBorn": 1951, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.0075, "open": 0.0074, "dayLow": 0.006, "dayHigh": 0.0075, "regularMarketPreviousClose": 0.0075, "regularMarketOpen": 0.0074, "regularMarketDayLow": 0.006, "regularMarketDayHigh": 0.0075, "beta": 0.436, "volume": 650, "regularMarketVolume": 650, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fiftyTwoWeekLow": 0.006, "fiftyTwoWeekHigh": 0.0075, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "profitMargins": 0.0, "floatShares": 5822414, "bookValue": 0.15, "priceToBook": 0.049999997, "netIncomeToCommon": -5647785, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 0.0075, "recommendationKey": "none", "totalCash": 1055805, "totalCashPerShare": 0.155, "ebitda": -5205665, "totalDebt": 0, "quickRatio": 1.338, "currentRatio": 1.802, "returnOnAssets": -0.94907, "returnOnEquity": -2.31868, "freeCashflow": -2810621, "operatingCashflow": -4541160, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PTIXW", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.0075, "marketState": "PRE", "shortName": "Protagenic Therapeutics, Inc. Warrant", "longName": "Protagenic Therapeutics, Inc.", "corporateActions": [], "regularMarketTime": 1743537600, "exchange": "NCM", "messageBoardId": "finmb_133204458", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": 0.0, "regularMarketDayRange": "0.006 - 0.0075", "fullExchangeName": "NasdaqCM", "fiftyTwoWeekLowChange": 0.0014999998, "fiftyTwoWeekLowChangePercent": 0.24999996, "fiftyTwoWeekRange": "0.006 - 0.0075", "fiftyTwoWeekHighChange": 0.0, "fiftyTwoWeekHighChangePercent": 0.0, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-04-27", "cryptoTradeable": false, "hasPrePostMarketData": true, "displayName": "Protagenic Therapeutics", "trailingPegRatio": null}